Biotech | March 16, 2026
This study demonstrates the power of real-time glucose information for people with Type 2 diabetes treated with basal insulin
The approval means US laboratories can now run both respiratory and gastrointestinal panels on the high-throughput QIAstat-Dx Rise
Cadila Pharmaceuticals’ journey has been marked by several milestones, including the development of indigenous formulations, expansion into global markets, and the creation of robust manufacturing and R&D capabilities
The trial’s primary goal is to evaluate vipoglanstat’s effect on endometriosis-related pain during non-menstrual days
The new entity will operate with separate resources, funding, and operations, while BioNTech will contribute related rights and mRNA technologies to support its ambitious mission
The move comes as China rapidly expands its capabilities in the pharmaceutical sector, particularly in licensing and drug development
One task, one interaction, one pair, experts advocate
Remidex manufactures micronutrient premixes and nutraceuticals,
Subscribe To Our Newsletter & Stay Updated
